Harms of PSA screening outweigh benefits for most men, says American College of Physicians

BMJ 2013; 346 doi: http://dx.doi.org/10.1136/bmj.f2232 (Published 9 April 2013)
Cite this as: BMJ 2013;346:f2232

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Michael McCarthy
  1. 1Seattle

Men aged 50 to 69 years should have prostate specific antigen (PSA) tests only after discussing with their physicians the “limited potential benefits and substantial harms of screening for prostate cancer,” say new guidelines published on 9 April by the American College of Physicians.

“Only men between the ages of 50 and 69 who express a clear preference for screening should have the PSA test,” said David Bronson, president of the college.

“For most of these men, the harms will outweigh the benefits,” he added.

Men who have an average risk for prostate cancer, who are younger than 50 years, men older than 69 years, …

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Article access

Article access for 1 day

Purchase this article for £20 $30 €32*

The PDF version can be downloaded as your personal record

* Prices do not include VAT

THIS WEEK'S POLL